A Virtual Network to Investigate the Clinical Epidemiology of Influenza and the Effectiveness of Influenza Vaccines
- Notice type
- Sources Sought
- NAICS industry
- 541380 · Testing Laboratories and Services
- Product or service code
- Q301 · REFERENCE LABORATORY TESTING
- Set-aside
- Not specified
- Place of performance
- ATLANTA, GA
- Official notice
- View on SAM.gov ↗
Description
Centers for Disease Control (CDC) is issuing this synopsis as a means of conducting market research to identify parties having an interest in and the resources to support this requirement for a California-based integrated health care system to serve as an electronic health record site in CDC’s VISION 2.0 respiratory pathogen surveillance network, providing integrated, longitudinal medical, laboratory, pharmacy, vaccination, claims, and outcomes data to support influenza surveillance, vaccine-effectiveness studies, and related respiratory pathogen research across emergency/urgent care, inpatient, and intensive care unit (ICU) settings. The result of this market research will contribute to determining the method of acquisition. The applicable North American Industry Classification System (NAICS) code assigned to this acquisition is 541380- Testing Laboratories and Services.
The rest of this notice
The buyer's named contact and the award details for this notice are free. Create an account to open the full record.
- Contact the buyer directly
- See who won, and for how much
- Get alerts for opportunities like this one
Free — no card, no trial clock.
